Tumor burden and heterogenous treatment effect of apalutamide in metastatic castration-sensitive prostate cancer. Fukuokaya W, Mori K, Yanagisawa T, Urabe F, et al. Cancer 2025;131:e35819.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fukuokaya W, Mori K, Yanagisawa T, Urabe F, et al. Tumor burden and heterogenous treatment effect of apalutamide in metastatic castration-sensitive prostate cancer. Cancer 2025;131:e35819.
PMID: 40106307